Voriconazole in the Treatment of Fungal Osteomyelitis of the Orbit in the Immunocompromised Host

Abstract

Scedosporium apiospermum is an uncommon cause of fungal infection in the orbit and sinus. Morbidity and mortality rates in immunocompromised patients are high. We review the first case of Scedosporium apiospermum orbito-sinus infection that was successfully treated with the new antifungal agent voriconazole. We highlight the efficacy of this drug, particularly in the treatment of osteomyelitis of the orbit and sinus, which may lead to an improvement in survival rates after Scedosporium infection.

KEYWORDS:

• Fungus infection
• orbital osteomyelitis
• Scedosporium
• voriconazole
• osteomyelitis
• immunocompromised host
• mortality rate